))
Ep. 47: What's New With eCW: 2023 Conference in Nashville Takeaways
Manage episode 385086578 series 2860835
Kandungan disediakan oleh Medical Advantage. Semua kandungan podcast termasuk episod, grafik dan perihalan podcast dimuat naik dan disediakan terus oleh Medical Advantage atau rakan kongsi platform podcast mereka. Jika anda percaya seseorang menggunakan karya berhak cipta anda tanpa kebenaran anda, anda boleh mengikuti proses yang digariskan di sini https://ms.player.fm/legal.
Want to get caught up on what you missed at the 2023 eClinicalWorks Conference? Join host Rebekah Duke, along with our attendees for a lively recap of the conference and what exciting new AI enhancements were presented.
…
continue reading
Once again, Medical Advantage sent a team of consultants to the annual eClinicalWorks conference. This year, it was held in Nashville, TN from October 20-22. Our team, including Business Development Consultant Bailey Sutherland, and Optimization Consultants Bonnie Rapchak and Jordin Crystal, were busy gathering everything they need to know about eCW's new features and enhancements for V12, with a special focus on the use of AI technology to make healthcare work easier. They share their takeaways in this podcast episode, so tune in to hear all about it.
What can we expect from the rollout of V12 starting from December 15th? How will these updated features and enhancements impact our day-to-day operations and the patient experience? We answer all these questions (and more) in our roundtable debrief, covering the highlights of the conference including what's new with Prisma, eClinicalTouch, RTBC/PA, EBO, and more!
Thank you for listening to the Medical Advantage Podcast, where each we take time each episode to discuss the ideas and technologies changing healthcare, and the best practices your organization can take to stay productive and profitable. Subscribe wherever you get your podcasts to ensure you never miss an episode.
Hosted on Acast. See acast.com/privacy for more information.
50 episod
Kongsi
